Roche Hungary Signs Strategic Cooperation Agreement

One of the largest companies in the healthcare industry, Roche Hungary Ltd., known for its innovative solutions, has signed a strategic cooperation agreement with the Hungarian government. The aim of the agreement is to use Roche's value-based healthcare model to multiply the innovative and personalized therapies delivered to patients in a way that significantly reduces their social costs and benefits the well-being of Hungarian patients.

A press statement by Swiss-based Roche, which turns 125 this year, says it is a major player in the Hungarian healthcare market, providing patients with quality of life-enhancing medical solutions through more than 70 products in oncology, hematology, immunology, neurology and pulmonology, and working to help Hungarian decision-makers develop a sustainable healthcare system through its research and international experience.

The strategic agreement signed today aims to use Roche's value-based healthcare model to multiply the innovative and personalized therapies delivered to patients, while significantly reducing their cost to society and improving the well-being of Hungarian patients. The agreement will connect decision-makers, innovative healthcare companies and Hungarian academia, which through research and development will be able to join networks that are at the forefront of healthcare worldwide and deliver cutting-edge digital solutions.

Roche, which has been present in Hungary for more than 35 years, is providing Hungarian patients with innovative therapies that move medicine towards personalized medicine through clinical trials in addition to its products.

The Roche Group is also at the forefront of job creation, continuously expanding its workforce, now employing more than 1,750 people, and this year increasing the number of employees at Roche Europe Services Ltd. by 300. As a major player in the business services sector, Roche supports its employees in more than 60 countries outside Hungary. In recent years, Roche Europe Service has brought more and more high value-added assignments to Hungary and is working to further strengthen the sector's presence in Hungary.

Roche is one of the companies that invests the majority of its revenues in Hungary, which for the biotech company means that three quarters of its annual revenues are reinvested in the Hungarian economy.

Roche has built up a pharmaceutical, diagnostics, diabetes business, a service center in Hungary and most recently a European pharmacovigilance and quality assurance center, which contributes to the safety and well-being of patients across Europe through the activities of its highly skilled employees. Roche offers partnership not only to decision-makers but also to Hungarian companies. 77 Elektronika Ltd., which started as a family business and is now present in more than 100 countries around the world, has reached a milestone in its life with the agreement with Roche, which opened the international healthcare market to the Hungarian company.